Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7181 |
Intermediate Similarity |
NPD5461 |
Discontinued |
0.708 |
Intermediate Similarity |
NPD2893 |
Phase 3 |
0.6992 |
Remote Similarity |
NPD1600 |
Suspended |
0.6962 |
Remote Similarity |
NPD8261 |
Discontinued |
0.6936 |
Remote Similarity |
NPD2008 |
Discontinued |
0.6904 |
Remote Similarity |
NPD2411 |
Approved |
0.6829 |
Remote Similarity |
NPD6173 |
Approved |
0.6794 |
Remote Similarity |
NPD8484 |
Phase 2 |
0.679 |
Remote Similarity |
NPD5524 |
Approved |
0.679 |
Remote Similarity |
NPD5523 |
Approved |
0.6763 |
Remote Similarity |
NPD8458 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD460 |
Discontinued |
0.6736 |
Remote Similarity |
NPD8488 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD2847 |
Phase 2 |
0.6736 |
Remote Similarity |
NPD2442 |
Approved |
0.6736 |
Remote Similarity |
NPD2443 |
Approved |
0.6708 |
Remote Similarity |
NPD3968 |
Approved |
0.6708 |
Remote Similarity |
NPD7971 |
Clinical (unspecified phase) |
0.6708 |
Remote Similarity |
NPD2408 |
Discontinued |
0.6708 |
Remote Similarity |
NPD7970 |
Approved |
0.668 |
Remote Similarity |
NPD3353 |
Approved |
0.6667 |
Remote Similarity |
NPD7557 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD3497 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2879 |
Approved |
0.6667 |
Remote Similarity |
NPD2881 |
Approved |
0.6638 |
Remote Similarity |
NPD3469 |
Phase 3 |
0.6627 |
Remote Similarity |
NPD5046 |
Discontinued |
0.6625 |
Remote Similarity |
NPD3411 |
Phase 2 |
0.6625 |
Remote Similarity |
NPD3905 |
Phase 3 |
0.6625 |
Remote Similarity |
NPD3410 |
Approved |
0.6614 |
Remote Similarity |
NPD6164 |
Phase 2 |
0.6614 |
Remote Similarity |
NPD6165 |
Phase 2 |
0.6586 |
Remote Similarity |
NPD5001 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD3915 |
Approved |
0.6583 |
Remote Similarity |
NPD3967 |
Approved |
0.6581 |
Remote Similarity |
NPD8641 |
Approved |
0.6574 |
Remote Similarity |
NPD7711 |
Discontinued |
0.6573 |
Remote Similarity |
NPD6210 |
Phase 3 |
0.656 |
Remote Similarity |
NPD3284 |
Phase 3 |
0.6559 |
Remote Similarity |
NPD6628 |
Discontinued |
0.6557 |
Remote Similarity |
NPD3916 |
Clinical (unspecified phase) |
0.6557 |
Remote Similarity |
NPD3917 |
Approved |
0.6557 |
Remote Similarity |
NPD3918 |
Approved |
0.6556 |
Remote Similarity |
NPD8410 |
Clinical (unspecified phase) |
0.6535 |
Remote Similarity |
NPD5935 |
Discontinued |
0.6527 |
Remote Similarity |
NPD4924 |
Clinical (unspecified phase) |
0.6508 |
Remote Similarity |
NPD5887 |
Clinical (unspecified phase) |
0.6502 |
Remote Similarity |
NPD5510 |
Approved |
0.6488 |
Remote Similarity |
NPD6328 |
Clinical (unspecified phase) |
0.6475 |
Remote Similarity |
NPD5072 |
Discontinued |
0.6468 |
Remote Similarity |
NPD5986 |
Approved |
0.6468 |
Remote Similarity |
NPD5987 |
Approved |
0.6466 |
Remote Similarity |
NPD5199 |
Approved |
0.6466 |
Remote Similarity |
NPD5198 |
Approved |
0.6462 |
Remote Similarity |
NPD6715 |
Discontinued |
0.6461 |
Remote Similarity |
NPD7981 |
Discontinued |
0.646 |
Remote Similarity |
NPD3108 |
Clinical (unspecified phase) |
0.6456 |
Remote Similarity |
NPD2880 |
Discontinued |
0.6452 |
Remote Similarity |
NPD2812 |
Clinical (unspecified phase) |
0.6452 |
Remote Similarity |
NPD2813 |
Phase 3 |
0.6449 |
Remote Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.6444 |
Remote Similarity |
NPD3347 |
Clinical (unspecified phase) |
0.6437 |
Remote Similarity |
NPD7860 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6429 |
Remote Similarity |
NPD465 |
Clinical (unspecified phase) |
0.6429 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6429 |
Remote Similarity |
NPD2947 |
Clinical (unspecified phase) |
0.6426 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.642 |
Remote Similarity |
NPD3840 |
Phase 2 |
0.642 |
Remote Similarity |
NPD3839 |
Phase 2 |
0.642 |
Remote Similarity |
NPD1506 |
Discontinued |
0.642 |
Remote Similarity |
NPD7834 |
Approved |
0.6417 |
Remote Similarity |
NPD5333 |
Clinical (unspecified phase) |
0.6408 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.6408 |
Remote Similarity |
NPD7465 |
Suspended |
0.6393 |
Remote Similarity |
NPD7232 |
Discontinued |
0.6392 |
Remote Similarity |
NPD7888 |
Approved |
0.6392 |
Remote Similarity |
NPD7887 |
Approved |
0.639 |
Remote Similarity |
NPD3015 |
Discontinued |
0.6386 |
Remote Similarity |
NPD8258 |
Clinical (unspecified phase) |
0.6386 |
Remote Similarity |
NPD8271 |
Discontinued |
0.6386 |
Remote Similarity |
NPD8257 |
Approved |
0.6386 |
Remote Similarity |
NPD8256 |
Approved |
0.6378 |
Remote Similarity |
NPD8075 |
Discontinued |
0.6364 |
Remote Similarity |
NPD6752 |
Phase 1 |
0.6364 |
Remote Similarity |
NPD6753 |
Phase 1 |
0.6364 |
Remote Similarity |
NPD7661 |
Clinical (unspecified phase) |
0.636 |
Remote Similarity |
NPD7241 |
Phase 3 |
0.636 |
Remote Similarity |
NPD7242 |
Phase 3 |
0.6352 |
Remote Similarity |
NPD8493 |
Clinical (unspecified phase) |
0.6349 |
Remote Similarity |
NPD6837 |
Clinical (unspecified phase) |
0.6349 |
Remote Similarity |
NPD7903 |
Clinical (unspecified phase) |
0.6349 |
Remote Similarity |
NPD5017 |
Discontinued |
0.6348 |
Remote Similarity |
NPD717 |
Approved |
0.634 |
Remote Similarity |
NPD5685 |
Approved |
0.634 |
Remote Similarity |
NPD5686 |
Approved |
0.6333 |
Remote Similarity |
NPD6137 |
Clinical (unspecified phase) |
0.6331 |
Remote Similarity |
NPD5679 |
Clinical (unspecified phase) |
0.6318 |
Remote Similarity |
NPD8119 |
Discontinued |
0.6316 |
Remote Similarity |
NPD4863 |
Approved |
0.631 |
Remote Similarity |
NPD5827 |
Discontinued |
0.6305 |
Remote Similarity |
NPD6481 |
Clinical (unspecified phase) |
0.6295 |
Remote Similarity |
NPD6171 |
Clinical (unspecified phase) |
0.6293 |
Remote Similarity |
NPD7415 |
Suspended |
0.629 |
Remote Similarity |
NPD276 |
Clinical (unspecified phase) |
0.6289 |
Remote Similarity |
NPD8292 |
Phase 2 |
0.6285 |
Remote Similarity |
NPD4414 |
Discontinued |
0.6282 |
Remote Similarity |
NPD4940 |
Approved |
0.6281 |
Remote Similarity |
NPD3891 |
Phase 2 |
0.6281 |
Remote Similarity |
NPD3890 |
Phase 2 |
0.6279 |
Remote Similarity |
NPD8316 |
Phase 2 |
0.6279 |
Remote Similarity |
NPD8317 |
Phase 2 |
0.6275 |
Remote Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.6266 |
Remote Similarity |
NPD2096 |
Phase 2 |
0.6266 |
Remote Similarity |
NPD2091 |
Phase 2 |
0.626 |
Remote Similarity |
NPD4612 |
Discontinued |
0.626 |
Remote Similarity |
NPD6486 |
Approved |
0.626 |
Remote Similarity |
NPD6487 |
Approved |
0.6259 |
Remote Similarity |
NPD4438 |
Approved |
0.6255 |
Remote Similarity |
NPD5818 |
Discontinued |
0.6255 |
Remote Similarity |
NPD2009 |
Clinical (unspecified phase) |
0.625 |
Remote Similarity |
NPD3178 |
Discontinued |
0.625 |
Remote Similarity |
NPD963 |
Discontinued |
0.6245 |
Remote Similarity |
NPD7289 |
Clinical (unspecified phase) |
0.6245 |
Remote Similarity |
NPD6579 |
Phase 2 |
0.6234 |
Remote Similarity |
NPD8113 |
Phase 2 |
0.6231 |
Remote Similarity |
NPD8047 |
Clinical (unspecified phase) |
0.623 |
Remote Similarity |
NPD5533 |
Discontinued |
0.6229 |
Remote Similarity |
NPD5016 |
Approved |
0.6226 |
Remote Similarity |
NPD7694 |
Discontinued |
0.6225 |
Remote Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.6224 |
Remote Similarity |
NPD1982 |
Phase 1 |
0.6223 |
Remote Similarity |
NPD2095 |
Phase 2 |
0.6223 |
Remote Similarity |
NPD2094 |
Phase 2 |
0.6223 |
Remote Similarity |
NPD2092 |
Phase 2 |
0.622 |
Remote Similarity |
NPD6381 |
Phase 2 |
0.6218 |
Remote Similarity |
NPD1896 |
Approved |
0.6217 |
Remote Similarity |
NPD8250 |
Phase 2 |
0.6215 |
Remote Similarity |
NPD1556 |
Clinical (unspecified phase) |
0.6214 |
Remote Similarity |
NPD8629 |
Discontinued |
0.621 |
Remote Similarity |
NPD7809 |
Clinical (unspecified phase) |
0.621 |
Remote Similarity |
NPD3843 |
Clinical (unspecified phase) |
0.6208 |
Remote Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.6207 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.6207 |
Remote Similarity |
NPD8159 |
Discontinued |
0.6207 |
Remote Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.6204 |
Remote Similarity |
NPD3379 |
Phase 2 |
0.6204 |
Remote Similarity |
NPD3380 |
Phase 3 |
0.6204 |
Remote Similarity |
NPD5901 |
Discontinued |
0.6204 |
Remote Similarity |
NPD4299 |
Phase 1 |
0.6203 |
Remote Similarity |
NPD2818 |
Discontinued |
0.6202 |
Remote Similarity |
NPD7767 |
Approved |
0.6202 |
Remote Similarity |
NPD7780 |
Approved |
0.6202 |
Remote Similarity |
NPD7781 |
Approved |
0.6201 |
Remote Similarity |
NPD1037 |
Clinical (unspecified phase) |
0.6201 |
Remote Similarity |
NPD7689 |
Approved |
0.6198 |
Remote Similarity |
NPD7621 |
Clinical (unspecified phase) |
0.6198 |
Remote Similarity |
NPD5665 |
Clinical (unspecified phase) |
0.6198 |
Remote Similarity |
NPD3425 |
Discontinued |
0.6196 |
Remote Similarity |
NPD5907 |
Phase 3 |
0.6194 |
Remote Similarity |
NPD4960 |
Approved |
0.6194 |
Remote Similarity |
NPD4959 |
Approved |
0.6192 |
Remote Similarity |
NPD2004 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD3805 |
Clinical (unspecified phase) |
0.619 |
Remote Similarity |
NPD5643 |
Phase 2 |
0.6189 |
Remote Similarity |
NPD8073 |
Approved |
0.6189 |
Remote Similarity |
NPD3914 |
Clinical (unspecified phase) |
0.6183 |
Remote Similarity |
NPD6986 |
Phase 1 |
0.6179 |
Remote Similarity |
NPD7568 |
Phase 1 |
0.6179 |
Remote Similarity |
NPD2849 |
Clinical (unspecified phase) |
0.6173 |
Remote Similarity |
NPD2911 |
Approved |
0.6173 |
Remote Similarity |
NPD2912 |
Approved |
0.6172 |
Remote Similarity |
NPD4070 |
Clinical (unspecified phase) |
0.6171 |
Remote Similarity |
NPD7850 |
Discontinued |
0.6171 |
Remote Similarity |
NPD7851 |
Phase 1 |
0.6157 |
Remote Similarity |
NPD4854 |
Phase 3 |
0.6151 |
Remote Similarity |
NPD2412 |
Clinical (unspecified phase) |
0.6145 |
Remote Similarity |
NPD6970 |
Phase 2 |
0.6145 |
Remote Similarity |
NPD7825 |
Clinical (unspecified phase) |
0.6144 |
Remote Similarity |
NPD2793 |
Discontinued |
0.6141 |
Remote Similarity |
NPD1871 |
Approved |
0.6141 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.6139 |
Remote Similarity |
NPD1571 |
Phase 2 |
0.6138 |
Remote Similarity |
NPD8272 |
Phase 2 |
0.6138 |
Remote Similarity |
NPD6229 |
Phase 2 |
0.6135 |
Remote Similarity |
NPD4341 |
Clinical (unspecified phase) |
0.6134 |
Remote Similarity |
NPD5171 |
Clinical (unspecified phase) |
0.613 |
Remote Similarity |
NPD3960 |
Clinical (unspecified phase) |
0.6129 |
Remote Similarity |
NPD4882 |
Clinical (unspecified phase) |
0.6126 |
Remote Similarity |
NPD8406 |
Clinical (unspecified phase) |
0.6122 |
Remote Similarity |
NPD2807 |
Discontinued |
0.6122 |
Remote Similarity |
NPD7052 |
Phase 1 |
0.6122 |
Remote Similarity |
NPD7321 |
Clinical (unspecified phase) |
0.6121 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.6119 |
Remote Similarity |
NPD7929 |
Approved |
0.6119 |
Remote Similarity |
NPD7928 |
Approved |
0.6118 |
Remote Similarity |
NPD3961 |
Discontinued |
0.6116 |
Remote Similarity |
NPD1952 |
Discontinued |
0.6111 |
Remote Similarity |
NPD3848 |
Phase 2 |
0.6111
|
Remote Similarity |
NPD8112 |
Clinical (unspecified phase) |